Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal topical insulin for wound healing after functional endoscopic sinus surgery in chronic rhinosinusitis
IRCT20210321050757N1Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human insulin in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Time to complete epithelialization. Started Nov 2026; status: recruiting.
02
Drugs
human insulin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20210321050757N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210321050757N1.